The same pattern was observed in the validation set for Basal I (3.58 % for gains and 0.13 % ) and Basal II (10.46 % for gains and 2.54 % ), also highly significant (Wilcoxon test: p -value = 1.11·10 −6 for gains and p -value = 5.37·10 −6 for losses).
← all excerpts
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes.
1
—
—